SSI Diagnostica A/S: Financial statements 2025
CVR: 37294535
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
SSI Diagnostica A/S (CVR 37294535) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 320,248,428 and a net result of DKK -107,420,232 compared with DKK -57,738,206 the year before. That is an increase of 34.4% compared with the year before. The profit margin was -33.5%. Equity in the 2025 report amounted to DKK 695,791,068. The solvency ratio was 23.4%. The company had 136 employees in the financial year.
- Revenue
- DKK 320,248,428
- Gross Profit
- DKK 110,465,407
- Profit/Loss
- DKK -107,420,232
- Equity
- DKK 695,791,068
- Total Assets
- DKK 2,976,120,148
- Employees
- 136
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 320.2M | 110.5M | -107.4M | 695.8M | 136 |
| 2024 | 238.3M | 121.5M | -57.7M | 1.3B | 121 |
| 2023 | 202.8M | 107.4M | -126.8M | 1.2B | 112 |
| 2022 | 316.1M | 115.7M | 38.1M | 1B | 125 |
| 2021 | - | 274.5M | 251.4M | 690.1M | 113 |
Official annual report
How creditworthy is SSI Diagnostica A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of December 18, 2025, Joseph Edward Bernardo has joined the board of directors of SSI Diagnostica A/S.
As of December 18, 2025, Stig Løkke Pedersen has left the board of directors of SSI Diagnostica A/S.
SSI Diagnostica A/S has won the tender "CE godkendt fuldautomatiseret system til dyrkning og resistensbestemmelse" issued by Region Syddanmark worth 22,000,000 DKK.
SSI Diagnostica A/S has published its annual report for 2024. Revenue came to DKK 238,337,916, and the net result was DKK -57,738,206.
As of May 16, 2025, Egil Mølsted Madsen has left the board of directors of SSI Diagnostica A/S.
As of January 1, 2025, Lars Henrik Vejrup Hansen is registered as director of SSI Diagnostica A/S.
About SSI Diagnostica A/S
SSI Diagnostica A/S is a Danish company of the type Aktieselskab based in Hillerød, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Christina Charlotte Lindved and Lars Henrik Vejrup Hansen. The board consists of Nachum Shamir (chair), Ingo Sujit Michael Chakravarty, Joseph Edward Bernardo and Patrik Olof Dahlén. The company is owned by SSI Diagnostica Holding A/S. The company has 151 employees (2026). In 2025, the company reported revenue of DKK 320,248,428 and a net result of DKK -107,420,232 compared with DKK -57,738,206 the year before. Equity in the 2025 report amounted to DKK 695,791,068.
